Affect Regulation Training for Pregnant Smokers

Smoking Cessation Clinical Trial

Official title:

Affect Regulation Training for Pregnant Smokers

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01163864
• Other study ID #: Q607
• Secondary ID: R01DA021802
• Status: Completed
• Phase: Phase 1/Phase 2
• Start date: September 2007
• Est. completion date: November 2011

Study information

• Verified date: October 2022
• Source: State University of New York at Buffalo
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Recent data indicate that approximately one-third of women of childbearing age smoke cigarettes, and 25-50% of women smoke during pregnancy. Cigarette smoking during pregnancy is a significant public health issue that can have profound effects on women's health and the health of their developing fetus. Smoking among pregnant women is associated with high levels of negative affect, which play a key role in the maintenance of smoking behavior and in difficulty quitting smoking during pregnancy. Despite the clear role of negative affect in the maintenance of smoking among pregnant women, and while this issue has received increased attention by clinicians and researchers, the investigators know of no smoking cessation intervention that combines coping skills and emotion regulation approaches to address the role of negative affect in smoking cessation. Smoking cessation treatment strategies that have demonstrated effectiveness in regular smokers have not translated into effective treatment strategies for pregnant women, particularly low-income pregnant women. The goal of this project is to develop and test an affect regulation smoking cessation intervention for low-income pregnant smokers.

The major aims of this project will be addressed in two sequential phases. In Phase 1, the investigators will develop two 8-session smoking cessation treatment manuals including: (a) Affect Regulation Training plus Cognitive-Behavioral Treatment (ART+CBT) and (b) a Health and Lifestyle plus Cognitive-Behavioral Treatment (HLS+CBT) control intervention. In Phase 2, the investigators will conduct a randomized clinical trial pilot study (Total N = 60) to compare the ART+CBT and HLS+CBT conditions on: a) the feasibility and acceptability of the interventions, (b) the impact of these interventions (ART+CBT and HLS+CBT) on smoking cessation rates at the end of the 8 treatment sessions (these occur approximately 2 months after treatment initiation) and at the 6-month post-quit date assessment (Session 2 is the quit date), (c) affect regulation skills, and (d) negative affect among pregnant smokers. The long-term goal of this proposed research is to increase smoking cessation rates among pregnant smokers, which would provide significant long-term health benefits for both mothers and their infants. This Stage 1 application will be used to generate feasibility and preliminary efficacy data, setting the stage for a Stage II efficacy trial.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 77
• Est. completion date: November 2011
• Est. primary completion date: November 2011
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 18 Years to 40 Years

Eligibility

Inclusion Criteria:

• 18-40 years of age,

• pregnancy involving single birth,

• less than 24 weeks pregnant,

• negative affect smoker,

• smoking at least 1 cigarette per day,

• no substance abuse diagnosis except marijuana,

• no more than .50 ounces of ethanol per day,

• can provide a collateral to verify smoking information.

Exclusion Criteria:

• acute psychosis,

• lack of familiarity with the English language.

Related Conditions & MeSH terms

• Smoking Cessation

Intervention

Behavioral:
• affect regulation training
8 sessions of a 1-hour long treatment intended to help women deal more effectively with negative affect; cognitive-behavioral smoking cessation intervention
• health and lifestyle
8 sessions of a 1-hour long treatment designed to help women improve their overall health; cognitive-behavioral smoking cessation intervention

Locations

Country	Name	City	State
United States	Research Institute on Addictions, University at Buffalo	Buffalo	New York

Sponsors (2)

Lead Sponsor	Collaborator
State University of New York at Buffalo	National Institute on Drug Abuse (NIDA)

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	smoking cessation rate using the Timeline Followback Interview for smoking	We will compare the number of women who are abstinent from smoking in the ART+CBT group vs. the HLS+CBT group using the Timeline Followback Interview for smoking	end of 8 session treatment (about 2 months after treatment initiation)
Secondary	smoking cessation rate using the Timelineline Followback Interview for smoking	We will compare the number of women who are abstinent from cigarettes in the ART+CBT group vs. the HLS+CBT group using the Timeline Followback Interview for smoking	6-month post-quit date (Session 2 is always the quit date)
Secondary	treatment feasibility	We will compare the number of women who complete the 8-session treatment in the ART+CBT vs. he HLS+CBT group.	end of 8-session treatment
Secondary	treatment acceptability	We will compare the treatment ratings by participants for the ART+CBT group vs. the HLS+CBT group using the Treatment Acceptability Questionnaire	end of 8-session treatment
Secondary	affect regulation skills	We will compare the scores on measures of affect regulation skills of ART+CBT group vs. HLS+CBT group using the Difficulties in Emotion Regulation Scale (DERS).	end of 8-session treatment
Secondary	negative affect	We will compare levels of negative at the end of treatment of the ART+CBT group vs. the HLS+CBT group using both Positive and Negative Affect Scale	end of 8-session treatment

External Links

•   Description of project on institutional website
•   Research Institute on Addiction website